Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8293)
All Articles published online
|
Publishing Process of This Article
|
Nov 15, 2015 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Benítez JM, García-Sánchez V. Faecal calprotectin: Management in inflammatory bowel disease. World J Gastrointest Pathophysiol 2015; 6(4): 203-209 [PMID: 26600978 DOI: 10.4291/wjgp.v6.i4.203] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v6/i4/203.htm |
| Number | Citing Articles |
| 1 |
Maxime M.W. De Sloovere, Dieter De Smet, Filip J. Baert, Johan Debrabandere, Hilde J.M. Vanpoucke. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease. Clinical Chemistry and Laboratory Medicine (CCLM) 2017; 55(9) doi: 10.1515/cclm-2016-0796
|
| 2 |
Efstathia Papada, Charalampia Amerikanou, Aristea Gioxari, Nick Kalogeropoulos, Andriana C. Kaliora. The Association of Plasma-Free Branched-Chain Amino Acids with Disease Related Parameters in Ulcerative Colitis. Diagnostics 2020; 10(10): 798 doi: 10.3390/diagnostics10100798
|
| 3 |
Rayna Shentova, Mila Baycheva, Petio Hadjiiski, Denitza Kofinova, Penka Yaneva. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterología y Hepatología (English Edition) 2020; 43(1): 57 doi: 10.1016/j.gastre.2019.08.005
|
| 4 |
Grazyna Piotrowicz, Agnieszka Klufczyńska, Jacek Kowerzanow, Piotr Banaszkiewicz,, Grażyna Rydzewska. Crohn’s disease activity evaluation based on imaging studies and biomarkers. Gastroenterology & Hepatology: Open Access 2018; 9(2) doi: 10.15406/ghoa.2018.09.00292
|
| 5 |
Sihem Ait‐Oudhia, Yi Ting (Kayla) Lien, Sumit Basu, Lawrence Lesko, Stephan Schmidt. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases. 2019; : 209 doi: 10.1002/9781119289234.ch10
|
| 6 |
Ella Serrano, Jean-Philippe Bastard, Laurence Trystram, Soraya Fellahi, Hedi A. Soula, Sophie Thenet, Jean-Michel Oppert, Karine Clément, Christine Poitou, Laurent Genser. Serum Versus Fecal Calprotectin Levels in Patients with Severe Obesity Before and 6 Months After Roux-Y-Gastric Bypass: Report of the Prospective Leaky-Gut Study. Obesity Surgery 2023; 33(12): 4017 doi: 10.1007/s11695-023-06911-w
|
| 7 |
Sebastián Eduardo Ibáñez Vodnizza, María Paz Poblete De La Fuente, Elisa Catalina Parra Cancino. Approach to the Patient with Axial Spondyloarthritis and Suspected Inflammatory Bowel Disease. Rheumatic Disease Clinics of North America 2020; 46(2): 275 doi: 10.1016/j.rdc.2020.01.004
|
| 8 |
E. Klang, U. Kopylov, R. Eliakim, N. Rozendorn, D. Yablecovitch, A. Lahat, S. Ben-Horin, M.M. Amitai. Diffusion-weighted imaging in quiescent Crohn's disease: correlation with inflammatory biomarkers and video capsule endoscopy. Clinical Radiology 2017; 72(9): 798.e7 doi: 10.1016/j.crad.2017.04.006
|
| 9 |
Rayna Shentova, Mila Baycheva, Petio Hadjiiski, Denitza Kofinova, Penka Yaneva. Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis. Gastroenterología y Hepatología 2020; 43(1): 57 doi: 10.1016/j.gastrohep.2019.08.011
|
| 10 |
Anet A. Soubières, Andrew Poullis. Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2016; 22(8): 2016 doi: 10.1097/MIB.0000000000000836
|
| 11 |
Vanesa Jusué, María Chaparro, Javier P. Gisbert. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease. Digestive and Liver Disease 2018; 50(4): 353 doi: 10.1016/j.dld.2017.12.022
|
| 12 |
Mohammed Al-Beltagi, Nermin Kamal Saeed, Adel Salah Bediwy, Reem Elbeltagi. Fecal calprotectin in pediatric gastrointestinal diseases: Pros and cons. World Journal of Clinical Pediatrics 2024; 13(2): 93341 doi: 10.5409/wjcp.v13.i2.93341
|
| 13 |
Stelios Pavlidis, Calixte Monast, Matthew J. Loza, Patrick Branigan, Kiang F. Chung, Ian M. Adcock, Yike Guo, Anthony Rowe, Frédéric Baribaud, Atle van Beelen Granlund. I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment. PLOS Computational Biology 2019; 15(4): e1006951 doi: 10.1371/journal.pcbi.1006951
|
| 14 |
Marisa Iborra, Belén Beltrán, Pilar Nos. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 2016; 26(4): 641 doi: 10.1016/j.giec.2016.06.005
|
| 15 |
Laurent Genser, Doriane Aguanno, Hédi A Soula, Liping Dong, Laurence Trystram, Karen Assmann, Joe‐Elie Salem, Jean‐Christophe Vaillant, Jean‐Michel Oppert, Fabienne Laugerette, Marie‐Caroline Michalski, Philippe Wind, Monique Rousset, Edith Brot‐Laroche, Armelle Leturque, Karine Clément, Sophie Thenet, Christine Poitou. Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes. The Journal of Pathology 2018; 246(2): 217 doi: 10.1002/path.5134
|
| 16 |
Shahzeb Saeed, Chukwuyem Ekhator , Ali M Abdelaziz, Husnain Naveed, Amanda Karski , Daniel E Cook, Shivani M Reddy, Maryam Affaf, Salman J Khan, Sophia B Bellegarde, Abdur Rehman , Abdul Haseeb Hasan, Abdullah Shehryar. Revolutionizing Inflammatory Bowel Disease Management: A Comprehensive Narrative Review of Innovative Dietary Strategies and Future Directions. Cureus 2023; doi: 10.7759/cureus.44304
|
| 17 |
Lili Wei, Mingwen Liu, Haofei Xiong. Role of Calprotectin as a Biomarker in Periodontal Disease. Mediators of Inflammation 2019; 2019: 1 doi: 10.1155/2019/3515026
|
| 18 |
Alexandre Jentzer, Anne-Emmanuelle Depincé-Berger, Christian Genin, Xavier Roblin, Stéphane Paul. Nouveaux marqueurs diagnostiques et pronostiques des maladies chroniques inflammatoires intestinales. Revue Francophone des Laboratoires 2016; 2016(484): 49 doi: 10.1016/S1773-035X(16)30223-4
|
| 19 |
Kata Judit Szántó, Tamara Madácsy, Diána Kata, Tamás Ferenci, Mariann Rutka, Anita Bálint, Renáta Bor, Anna Fábián, Ágnes Milassin, Boldizsár Jójárt, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Imre Földesi, József Maléth, Klaudia Farkas. Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists. Expert Opinion on Biological Therapy 2021; 21(4): 539 doi: 10.1080/14712598.2021.1890712
|
| 20 |
Fernando Magro, Joana Afonso, Susana Lopes, Rosa Coelho, Raquel Gonçalves, Paulo Caldeira, Paula Lago, Helena Tavares de Sousa, Jaime Ramos, Ana Rita Gonçalves, Paula Ministro, Isadora Rosa, Ana Isabel Vieira, Patrícia Andrade, João-Bruno Soares, Diana Carvalho, Paula Sousa, Tânia Meira, Joanne Lopes, Joana Moleiro, Cláudia Camila Dias, Amílcar Falcão, Karel Geboes, Fatima Carneiro. Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation. EBioMedicine 2017; 21: 123 doi: 10.1016/j.ebiom.2017.06.004
|
| 21 |
Manoj Kumar, Selvasankar Murugesan, Nazira Ibrahim, Mamoun Elawad, Souhaila Al Khodor. Predictive biomarkers for anti-TNF alpha therapy in IBD patients. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05058-1
|
| 22 |
Anuraag Jena, Vishal Sharma, Usha Dutta. Fecal calprotectin in cirrhosis—Does “ESR” of the intestine measure the liver dysfunction too?. Indian Journal of Gastroenterology 2023; 42(6): 754 doi: 10.1007/s12664-023-01481-2
|